-
Granek L, Mizrakli Y, Ariad S, Jotkowitz A, Geffen DB. Impact of a 3-day Oncology Course on First-Year International Medical Students. J Cancer Educ,( Epub ahead of print), Feb. 5, 2016.
-
Stemmer, S.M., Klang,S.H., Efrat, N., Geffen, D.B., Steiner, M. Soussan-Gutman, L., Merling, S., Svedman, C., Rizel, S., Lieberman, N. The impact of the 21-gene Recurrence Score assay on clinical decision making in node-positive (up to 3 positive nodes) estrogen receptor-positive breast cancer patients. Breast Cancer Res. Treat. 140: 83-92, 2013.
-
Geffen, D.B., Tokar, M., Abu-Ghanem S., Braunstein, R., Koretz, M., Amir, N., Delgado, B., Sion-Vardi, N., Ariad, S., Lazarev, I. Adjuvant aromatase inhibitor therapy in patients with stage I breast cancer at a regional oncology center in Israel: Implementation of a “switching” policy in post-menopausal patients after initial tamoxifen. Oncology 85:145-152, 201328.
-
Fraenkel M., Novack, V., Liel, Y., Koretz, M., Siris, E., Norton, L., Shafat, T., Shany, S., Geffen, D.B. Association between bone mineral density and incidence of breast cancer. PLOS ONE 8:e70980,Aug 5, 2013.
-
Geffen, D.B., Abu-Ghanem, S., Sion-Vardy, N., Braunstein, R., Tokar, M., Ariad, Delgado, B., Bayme, M., Koretz, M. The impact of the 21-gene recurrence score assay on decision making about adjuvant chemotherapy in early-stage estrogen-receptor-positive breast cancer in an oncology practice with a unified treatment policy. Ann Oncol advanced access published March 1, 2011.
-
Geffen, D.B., Amir,N., Sion-Vardy, N., Ariad S., Kachko L., Bayme, M., Delgado, B., Dyomin, V., Argov, S., Koretz, M. Stage I breast cancer in a regional oncology practice in Israel 2002-2006: Clinicopathologic features, risk estimation and planned therapy of 328 consecutive patients. The Breast 18:316-321, 2009.
-
Geffen, D.B, Man, S. New Drugs for the Treatment of Cancer 1990-2001. Isr. Med. Assoc. J. 4: 1124-1131, 2002.
-
Geffen, D.B., Fisher, R.I., Longo, D.L., Young, R.C., DeVita Jr., VT. Renal involvement in diffuse aggressive lymphomas; treatment with combination chemotherapy. J. Clin. Oncol. 3:646-653, 1985.